Showing 1 - 8 results of 8 for search 'Vishal H. Oza', query time: 0.04s Refine Results
  1. 1
    Random Forest Analysis of Untargeted Metabolomics Data Suggests Increased Use of Omega Fatty Acid Oxidation Pathway in Drosophila Melanogaster Larvae Fed a Medium Chain Fatty Acid Rich High-Fat Diet

    Random Forest Analysis of Untargeted Metabolomics Data Suggests Increased Use of Omega Fatty Acid Oxidation Pathway in Drosophila Melanogaster Larvae Fed a Medium Chain Fatty Acid... by Vishal H. Oza, Joseph K. Aicher, Laura K. Reed

    Published 2018-12-01
    Get full text
    Article
  2. 2
    CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability

    CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability by Vishal H. Oza, Jennifer L. Fisher, Roshan Darji, Brittany N. Lasseigne

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers

    Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers by Sasha Taluri, Vishal H. Oza, Tabea M. Soelter, Jennifer L. Fisher, Brittany N. Lasseigne

    Published 2023-12-01
    Get full text
    Article
  4. 4
    Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq

    Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq by Tabea M. Soelter, Timothy C. Howton, Amanda D. Clark, Vishal H. Oza, Brittany N. Lasseigne

    Published 2024-06-01
    Get full text
    Article
  5. 5
    Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates

    Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates by Jennifer L. Fisher, Elizabeth J. Wilk, Vishal H. Oza, Sam E. Gary, Timothy C. Howton, Victoria L. Flanary, Amanda D. Clark, Anita B. Hjelmeland, Brittany N. Lasseigne

    Published 2024-05-01
    Get full text
    Article
  6. 6
    Ten simple rules for using public biological data for your research

    Ten simple rules for using public biological data for your research by Vishal H. Oza, Jordan H. Whitlock, Elizabeth J. Wilk, Angelina Uno-Antonison, Brandon Wilk, Manavalan Gajapathy, Timothy C. Howton, Austyn Trull, Lara Ianov, Elizabeth A. Worthey, Brittany N. Lasseigne

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Ten simple rules for using public biological data for your research.

    Ten simple rules for using public biological data for your research. by Vishal H Oza, Jordan H Whitlock, Elizabeth J Wilk, Angelina Uno-Antonison, Brandon Wilk, Manavalan Gajapathy, Timothy C Howton, Austyn Trull, Lara Ianov, Elizabeth A Worthey, Brittany N Lasseigne

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

    Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion by Elizabeth J. Wilk, Timothy C. Howton, Jennifer L. Fisher, Vishal H. Oza, Ryan T. Brownlee, Kasi C. McPherson, Hannah L. Cleary, Bradley K. Yoder, James F. George, Michal Mrug, Brittany N. Lasseigne

    Published 2023-05-01
    Get full text
    Article

Search Tools: